Victory Capital Management Inc. Buys 1,016 Shares of Doximity, Inc. (NASDAQ:DOCS)

Victory Capital Management Inc. lifted its position in Doximity, Inc. (NASDAQ:DOCS) by 3.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 34,516 shares of the company’s stock after purchasing an additional 1,016 shares during the period. Victory Capital Management Inc.’s holdings in Doximity were worth $1,843,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Shaker Investments LLC OH purchased a new stake in Doximity during the 4th quarter valued at $559,000. Penserra Capital Management LLC bought a new position in shares of Doximity during the third quarter valued at about $2,384,000. Principal Financial Group Inc. boosted its holdings in shares of Doximity by 1.5% during the fourth quarter. Principal Financial Group Inc. now owns 293,974 shares of the company’s stock worth $15,695,000 after purchasing an additional 4,282 shares during the period. Newbridge Financial Services Group Inc. bought a new stake in shares of Doximity in the fourth quarter worth about $362,000. Finally, Stratos Wealth Partners LTD. purchased a new position in Doximity during the 4th quarter valued at about $203,000. 87.19% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

DOCS has been the subject of several research analyst reports. JPMorgan Chase & Co. increased their price objective on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Stephens started coverage on Doximity in a research note on Friday, December 20th. They issued an “equal weight” rating and a $55.00 price target for the company. Bank of America boosted their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Mizuho upped their price objective on shares of Doximity from $55.00 to $65.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. Finally, Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 37.40% of the stock is owned by insiders.

Doximity Trading Down 1.5 %

Doximity stock opened at $62.40 on Tuesday. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21. The company has a market capitalization of $11.65 billion, a price-to-earnings ratio of 62.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The business’s fifty day simple moving average is $63.77 and its two-hundred day simple moving average is $52.90.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.